Sunday, January 16, 2022

Clinical Tests for Iranian-Cuban COVID-19 Vaccine Begin

More Articles

Avatar of IFP Editorial Staff
IFP Editorial Staff
The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.
The Iranian health ministry has announced that clinical tests have begun for a coronavirus vaccine jointly developed by Iran and Cuba.

“Phase two of clinical tests for the vaccine produced by the Pasteur Institute of Iran and the Cuban Finlay Institute has kicked off in … Havana,” said Kianoush Jahanpour, the head of the Public Relations Office of the Iranian health ministry.

“In this phase, more than 100 people ranging in age from 19 to 80 years old have been vaccinated so far. At this centre, too, 400 people will receive shots, and the total number of volunteers [for injection] will be around 900 at this stage,” he added.

Iran and Cuba have begun trials of a joint Covid-19 vaccine as Iran keeps fighting the coronavirus outbreak.

The Cuban vaccine, called Soberana 02, is the most advanced of Cuba’s four vaccine candidates and has been developed in cooperation between Cuba’s Finlay Vaccine Institute and Iran’s Pasteur Institute.

The cooperation between the two countries, both of which are under illegal US sanctions, reflects a shared drive for self-sufficiency and less reliance on imports from the West. The name of the vaccine, Soberana, is Spanish for “sovereign.”

Latest article